SeqLL (NASDAQ:SQL – Get Free Report) and TTEC (NASDAQ:TTEC – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk.
Volatility & Risk
SeqLL has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500. Comparatively, TTEC has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500.
Insider & Institutional Ownership
1.8% of SeqLL shares are owned by institutional investors. Comparatively, 38.6% of TTEC shares are owned by institutional investors. 22.3% of SeqLL shares are owned by company insiders. Comparatively, 59.3% of TTEC shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
TTEC has a consensus target price of $36.20, suggesting a potential upside of 98.46%. Given TTEC’s higher probable upside, analysts plainly believe TTEC is more favorable than SeqLL.
Valuation & Earnings
This table compares SeqLL and TTEC’s top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|TTEC||$2.44 billion||0.36||$103.24 million||$0.86||21.35|
TTEC has higher revenue and earnings than SeqLL. SeqLL is trading at a lower price-to-earnings ratio than TTEC, indicating that it is currently the more affordable of the two stocks.
This table compares SeqLL and TTEC’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
TTEC beats SeqLL on 11 of the 13 factors compared between the two stocks.
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. It focus on development of scientific assets and novel intellectual property across multiple omics fields. The company's True Single Molecule Sequencing technology (tSMS) platform offers a single molecule solution for DNA and RNA sequencing through detection of nucleic acids to researchers for analyzing many billions of single molecules in a single experiment and generate accurate and reproducible data. It provide solutions for various applications, such as biomarker discovery and diagnostic assay developments including laboratories associated with universities, scientific research centers, government institutions, and biotechnology and pharmaceutical companies. In addition, the company has research and development agreement with U.S. Department of Justice's Federal Bureau of Investigation to evaluate and determine the forensic capabilities of direct RNA sequencing using tSMS platform; and research collaboration with True Bearing Diagnostics, Inc. performing tSMS on whole-blood RNA to identify transcripts associated with coronary artery disease. Further, it has collaboration agreement with The Bernstein Laboratory to address fundamental questions in chromatin biology and epigenetic regulation; The Ting Laboratory; The Jackson Laboratory for Genomic Medicine assisting in the development of new methods for chromatin interaction analysis in single nuclei, with single-molecule resolution; Weizmann Institute of Science for developed and applied innovative single-molecule technologies; and Tetracore, Inc. to provide with tSMS systems and onsite support. The company was founded in 2013 and is headquartered in Billerica, Massachusetts.
TTEC Holdings, Inc., a customer experience technology and services company, that designs, builds, orchestrates, and delivers digitally enabled customer experiences designed for various brands. It operates in two segments, TTEC Digital and TTEC Engage. The TTEC Digital segments designs, builds, and operates robust digital experiences for clients and their customers through the contextual integration and orchestration of customer relationship management, data, analytics, customer experience as a service technology, and intelligent automation to ensure customer experience (CX) outcomes. The TTEC Engage segment provides digitally enabled CX managed services; delivers omnichannel customer care, technology support, order fulfillment, customer acquisition, growth, and retention services; and delivers digitally enabled back office and industry specific specialty services, including artificial intelligence (AI) operations, content moderation, and fraud management services. It serves clients in the automotive, communication, financial services, government, healthcare, logistics, media and entertainment, e-tail/retail, technology, transportation, and travel industries with operations in the United States, Australia, Belgium, Brazil, Bulgaria, Canada, Colombia, Costa Rica, Germany, Greece, India, Ireland, Mexico, the Netherlands, New Zealand, the Philippines, Poland, Singapore, South Africa, Thailand, and the United Kingdom. The company was formerly known as TeleTech Holdings, Inc. and changed its name to TTEC Holdings, Inc. in January 2018. TTEC Holdings, Inc. was founded in 1982 and is headquartered in Englewood, Colorado.
Receive News & Ratings for SeqLL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeqLL and related companies with MarketBeat.com's FREE daily email newsletter.